Stock Rich List
#5599 on the rich list of 14,644 insiders

Arie Belldegrun

Director at UroGen Pharma; Director at Allogene Therapeutics; Director at Ginkgo Bioworks Holdings. Based in South San Francisco, California.

$18.1M
in disclosed stock, +$572K (+3.26%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
5599th of 14,644
Companies held
3
Largest holding
URGN, 71.6% of total
Latest SEC filing
Feb 2, 2026
Listed but not counted
$2.3M

What the $18.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
UroGen Pharma URGN
Ordinary Shares
Directly408,693$31.73$13.0M71.6%Form 4, Sep 14, 2022
Allogene Therapeutics ALLO
Common Stock
Through Bellco Legacy Trust4,710,120$0.67$3.1M17.4%Form 4, Feb 2, 2026
Allogene Therapeutics ALLO
Common Stock
Directly2,236,816$0.67$1.5M8.2%Form 4, Feb 2, 2026
Allogene Therapeutics ALLO
Common Stock
Through Bellco Legacy LLC539,867$0.67$360K2.0%Form 4, Feb 2, 2026
Ginkgo Bioworks Holdings DNA
Class A Common Stock
Through Bellco Legacy LLC12,500
split-adjusted
$8.20$102K0.6%Form 4, Jun 12, 2024
Ginkgo Bioworks Holdings DNA
Class A Common Stock
Directly4,873
split-adjusted
$8.20$40K0.2%Form 4, Jun 12, 2024

Share counts are the amounts Arie Belldegrun reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Arie Belldegrun's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Allogene Therapeutics ALLO
Common Stock
Through Vida Ventures LLC
Held by an investment fund or partnership
1,798,163$0.67$1.2M—Form 4, Feb 2, 2026
Allogene Therapeutics ALLO
Common Stock
Through Vida Ventures III, L.P.
Held by an investment fund or partnership
1,724,137$0.67$1.1M—Form 4, Feb 2, 2026

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
5596Alex Bellos
PRESIDENT WEST ELM BRAND, Williams-Sonoma. San Francisco, CA
$18.1M−$3.2M (−15.16%)
5597Annmarie Gayle
Chairman, CEO, Coda Octopus Group. Orlando, FL
$18.1M−$514K (−2.76%)
5598Thomas C. Hutton
vice president, Chemed. New York, NY
$18.1M+$151K (+0.84%)
5599Arie Belldegrun
Director, UroGen Pharma. South San Francisco, CA
$18.1M+$572K (+3.26%)
5600Mark Stephen LaVigne
PRESIDENT AND CEO, Energizer Holdings. St. Louis, MO
$18.1M−$28K (−0.16%)
5601Roland O. Burns
President & CFO, Comstock Resources. Frisco, TX
$18.1M−$1.5M (−7.42%)
5602Brian E. Shore
Board Chairman & CEO, Park Aerospace. Westbury, NY
$18.1M−$427K (−2.31%)

Other UroGen Pharma insiders

All URGN insiders

Questions

How much stock does Arie Belldegrun own?

Arie Belldegrun holds $18,103,237 in listed stock based on SEC filings and current prices, mostly UroGen Pharma (URGN). That ranks 5599th on the Stock Rich List.

Is this Arie Belldegrun's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.